KOD Kodiak Sciences Inc

Price (delayed)

$7.92

Market cap

$411.47M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$6.01

Enterprise value

-$185.18M

Kodiak Sciences Inc. is a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat high prevalence retinal diseases. Founded in 2009, Kodiak is focused on bringing new ...

Highlights
Kodiak Sciences's net income has shrunk by 96% YoY and by 17% QoQ
The EPS has plunged by 79% YoY and by 16% from the previous quarter

Key stats

What are the main financial stats of KOD
Market
Shares outstanding
51.95M
Market cap
$411.47M
Enterprise value
-$185.18M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
0.69
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Earnings
Revenue
$0
EBIT
-$312.23M
EBITDA
-$303.51M
Free cash flow
-$265.61M
Per share
EPS
-$6.01
Free cash flow per share
-$5.09
Book value per share
$11.5
Revenue per share
$0
TBVPS
$16.3
Balance sheet
Total assets
$850.29M
Total liabilities
$252.9M
Debt
$81.4M
Equity
$597.38M
Working capital
$605.85M
Liquidity
Debt to equity
0.14
Current ratio
8.94
Quick ratio
8.88
Net debt/EBITDA
1.97
Margins
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Efficiency
Return on assets
-33.7%
Return on equity
-45.1%
Return on invested capital
-182.6%
Return on capital employed
-40.3%
Return on sales
N/A
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

KOD stock price

How has the Kodiak Sciences stock price performed over time
Intraday
-1.25%
1 week
-3.53%
1 month
14.45%
1 year
-91.29%
YTD
-90.66%
QTD
2.59%

Financial performance

How have Kodiak Sciences's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$312.26M
Net income
-$312.25M
Gross margin
N/A
Net margin
N/A
Kodiak Sciences's net income has shrunk by 96% YoY and by 17% QoQ
The operating income has plunged by 94% YoY and by 17% from the previous quarter

Growth

What is Kodiak Sciences's growth rate over time

Valuation

What is Kodiak Sciences stock price valuation
P/E
N/A
P/B
0.69
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
The EPS has plunged by 79% YoY and by 16% from the previous quarter
The stock's P/B is 86% below its last 4 quarters average of 5.1
The equity has declined by 27% year-on-year and by 10% since the previous quarter

Efficiency

How efficient is Kodiak Sciences business performance
KOD's ROIC has dropped by 97% year-on-year and by 12% since the previous quarter
KOD's return on equity has dropped by 61% year-on-year and by 26% since the previous quarter
The ROA has plunged by 60% YoY and by 23% from the previous quarter

Dividends

What is KOD's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for KOD.

Financial health

How did Kodiak Sciences financials performed over time
Kodiak Sciences's quick ratio has plunged by 67% YoY and by 22% from the previous quarter
KOD's current ratio has dropped by 66% year-on-year and by 21% since the previous quarter
KOD's debt is 86% lower than its equity
KOD's debt to equity has soared by 56% YoY and by 17% from the previous quarter
The equity has declined by 27% year-on-year and by 10% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.